NDAINTRAVENOUSSOLUTION
Approved
Aug 2016
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
3
Clinical Trials (3)
Netupitant and Palonosetron Hydrochloride in Preventing Chemotherapy Induced Nausea and Vomiting in Patients With Cancer Undergoing BEAM Conditioning Regimen Before Stem Cell Transplant
Started Apr 2017
43 enrolled
Malignant Neoplasm
Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer
Started Sep 2009
7 enrolled
Anal CancerCarcinoma of the AppendixColorectal Cancer+9 more
APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer
Started Jun 2006